New research sheds light on the molecular mechanisms by which a virus contributes to cancer

August 29, 2012
Cancer genomics: An integrative approach to liver cancer
© iStockphoto.com/somersault18:24

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and is associated with exposure to hepatitis B virus (HBV). Patients carrying the virus have a 100-fold greater risk of developing HCC, but exactly why was unclear until now. Wing Kin Sung at the A*STAR Genome Institute of Singapore and the National University of Singapore, John Luk at the A*STAR Institute of Molecular and Cell Biology and the National University of Singapore and co-workers have now identified genetic mechanisms by which a virus contributes to this common form of cancer.

To investigate, the researchers obtained samples of liver tumors and adjacent non-cancerous tissues from 88 Chinese HCC patients, and used advanced DNA sequencing technology to analyze their genomes for HBV integration sites. They identified 399 sites at which HBV was integrated into the genome, and found that they were randomly distributed across the whole genome, but that most were clustered within a small number of 'hotspots'. The vast majority of the integration sites (344 out of 399; more than 86%) were found only in the samples obtained from .

The researchers analyzed breakpoints in the HBV genome—sites at which the circular genome of the virus breaks before being integrated into the genome of the host cell. They found that about 40% of breakpoints occur within a restricted region where three critical genetic elements are located.

This region, approximately 400 base pairs in length, contains the enhancer, a short regulatory sequence that binds proteins and enhances expression of the viral genes; the X gene, which plays critical roles in infection and replication; and the core gene, which encodes a protein envelope for the viral DNA. The high number of breakpoints in the region may facilitate HBV insertion into the , which in turn may promote by interrupting the coding sequences of .

The researchers also examined the prevalence of HBV insertions in DNA obtained from HCC patients. More than 92% of the patients in the sample had HBV integrated into their genomes, and the majority of these were found only in DNA from the tumors.

Non-cancerous tissues were also found to contain integrated viral genomes, but DNA isolated from the tumors tended to have more HBV integration sites. Thus, HBV integration patterns differ between cancerous and non-cancerous tissues, and there is a complex relationship between HBV integration and cancer development.

Explore further: Scientists unravel mechanism that causes liver cancer

More information: Sung, W. K., Zheng, H., Li, S., Chen, R., Liu, X., et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nature Genetics 44, 765–769 (2012). Article

Related Stories

Scientists unravel mechanism that causes liver cancer

May 28, 2012
Scientists at the Genome Institute of Singapore (GIS) have unraveled the mechanism that causes liver cancer (hepatocellular carcinoma, HCC), one of the most common solid tumors worldwide. This genome-wide research was done ...

Androgen boosts hepatitis B virus replication

February 16, 2012
Androgen enhances replication of hepatitis B virus (HBV), rendering males more vulnerable than females to this virus, according to research published in the February Journal of Virology.

Family history of liver cancer increases risk of developing the disease

April 24, 2012
A family history of liver cancer is reported to increase risk of developing hepatocellular carcinomas (HCC), independent of hepatitis according to findings published in the May issue of Hepatology, a journal of the American ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.